“…Unlike 2D, 3D methods are less affected by the shape of LV cavity. When compared to other echocardiographic methods, LVEF evaluation using a 3D modality proved to be more accurate and far less variable [8,11]. However, whereas irregular geometry can be addressed by 3D imaging, limited image quality remains a potential issue with 3D echocardiography and the suboptimal spatial resolution may lead to the incorporation of the trabeculae in the myocardial tracing, hence affecting LV volume measurements [12].…”
“…The main disadvantage is the high dose of radiation exposure, which makes such techniques unsuitable in clinical conditions, requiring repeated measures of LVEF and volumes. Moreover, low temporal resolution may lead to an underestimation of LV volumes [11].…”
Section: Assessment Of LV Systolic Function Beyond Lvef: Myocardial Strainmentioning
confidence: 99%
“…Contrast echocardiography and 3D TTE have been proven to significantly improve the diagnostic accuracy of the standard 2D TTE, providing values for LV volumes and EF that strongly correlate with those of CMR, but their use is frequently limited mainly because of the need for i.v. access, specific ultrasound probes and expertise [1,9,11].…”
Section: Multimodality Imaging For Lvef Assessmentmentioning
The left ventricular (LV) ejection fraction (EF) is the preferred parameter applied for the non-invasive evaluation of LV systolic function in clinical practice. It has a well-recognized and extensive role in the clinical management of numerous cardiac conditions. Many imaging modalities are currently available for the non-invasive assessment of LVEF. The aim of this review is to describe their relative advantages and disadvantages, proposing a hierarchical application of the different imaging tests available for LVEF evaluation based on the level of accuracy/reproducibility clinically required.
“…Unlike 2D, 3D methods are less affected by the shape of LV cavity. When compared to other echocardiographic methods, LVEF evaluation using a 3D modality proved to be more accurate and far less variable [8,11]. However, whereas irregular geometry can be addressed by 3D imaging, limited image quality remains a potential issue with 3D echocardiography and the suboptimal spatial resolution may lead to the incorporation of the trabeculae in the myocardial tracing, hence affecting LV volume measurements [12].…”
“…The main disadvantage is the high dose of radiation exposure, which makes such techniques unsuitable in clinical conditions, requiring repeated measures of LVEF and volumes. Moreover, low temporal resolution may lead to an underestimation of LV volumes [11].…”
Section: Assessment Of LV Systolic Function Beyond Lvef: Myocardial Strainmentioning
confidence: 99%
“…Contrast echocardiography and 3D TTE have been proven to significantly improve the diagnostic accuracy of the standard 2D TTE, providing values for LV volumes and EF that strongly correlate with those of CMR, but their use is frequently limited mainly because of the need for i.v. access, specific ultrasound probes and expertise [1,9,11].…”
Section: Multimodality Imaging For Lvef Assessmentmentioning
The left ventricular (LV) ejection fraction (EF) is the preferred parameter applied for the non-invasive evaluation of LV systolic function in clinical practice. It has a well-recognized and extensive role in the clinical management of numerous cardiac conditions. Many imaging modalities are currently available for the non-invasive assessment of LVEF. The aim of this review is to describe their relative advantages and disadvantages, proposing a hierarchical application of the different imaging tests available for LVEF evaluation based on the level of accuracy/reproducibility clinically required.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.